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Anergy is a critical physiologic mechanism to censor
self-reactive B cells. However, a biochemical under-
standing of how anergy is achieved and maintained
is lacking. Herein, we investigated the role of the
phosphoinositide 3-kinase (PI3K) lipid product
PI(3,4,5)P3 in B cell anergy. We found reduced gener-
ation of PI(3,4,5)P3 in anergic B cells, which was
attributable to reduced phosphorylation of the PI3K
membrane adaptor CD19, as well as increased
expression of the inositol phosphatase PTEN. Sus-
tained production of PI(3,4,5)P3 in B cells, achieved
through conditional deletion of Pten, resulted in
failed tolerance induction and abundant autoanti-
body production. In contrast to wild-type immature
B cells, B cell receptor engagement of PTEN-defi-
cient immature B cells resulted in activation and
proliferation, indicating a central defect in early B
cell responsiveness. These findings establish repres-
sion of the PI3K signaling pathway as a necessary
condition to avert the generation, activation, and
persistence of self-reactive B cells.
INTRODUCTION
A large proportion of newly formed B cells express antigen
receptors possessing some degree of self-specificity. Hence,
the body is challenged with the necessity of providing an ample
pool of naive B cells capable of responding to diverse antigenic
challenges while preventing the release and/or activation of self-
reactive B cells. The consequences of self-antigen encounter is
governed by B cell receptor (BCR) signaling and can be influ-
enced by additional microenvironmental factors such as T cell-
derived factors, B cell-activating factor (BAFF) and Toll-like
receptor (TLR) ligands. The nature of the BCR signal has been
well described in terms of ‘‘signal strength’’ dictated by the
avidity and affinity of the BCR-antigen interaction. However, a
biochemical understanding of how these signals result in B cell
non-responsiveness (anergy), rapid apoptosis (deletion) or
continued Ig rearrangement (receptor editing) is a subject of
continuing investigation.Chronic exposure to antigen results in BCR desensitization,
which is associated with impaired proximal signaling via Syk
and Src family kinases, as well as the activation of some, but
not all, downstream pathways (Cambier et al., 2007; Jun and
Goodnow, 2003). Similarly, ablation of genes encoding negative
or positive regulators of BCR signaling affect threshold-based
negative (and positive) selection of emergent B cells (Cornall
et al., 1998; Cyster et al., 1996). In addition to alterations in intra-
cellular signaling, it is apparent that chronic engagement of the
BCR also causes a redistribution of the BCR complex, first noted
by the selective downregulation of surface IgM and, more
recently, by evidence for disengagement of Ig-a-Ig-b signaling
moieties, as well as a redistribution of BCR components in
membrane microdomains (Goodnow et al., 1988; Vilen et al.,
1999; Weintraub et al., 2000). Importantly, anergy is a reversible
process and thus, mechanisms need to be in place to sustain
the anergic state (Gauld et al., 2005; Goodnow et al., 1991).
Anergic B cells exhibit low basal Ca2+ oscillations sufficient to
activate calcineurin-dependent nuclear factor of activated
T cells (NF-AT), but are refractory to induced Ca2+ flux (Healy
et al., 1997). ERK activity is also elevated in the basal state,
but is poorly induced in anergic B cells (Healy et al., 1997). Auto-
antibody production by anergic B cellsmay be prevented by sus-
tained ERK signaling because this exerts an inhibitory effect on
CpG-TLR9- and LPS-TLR4-dependent plasma cell differentia-
tion (Rui et al., 2006; Rui et al., 2003). Activation of JNK and
classical NF-kB are also impaired in anergic B cells, but experi-
mental evidence is lacking as to the causative relationship of
these pathways to the anergic state. Interestingly, PKCd has
emerged as an important regulator of B cell tolerance through
the integration of signals via the BCR as well as BAFF-R
(Mecklenbrauker et al., 2004; Mecklenbrauker et al., 2002). In
particular, nuclear translocation of PKCd appears to be a critical
regulatory event in promoting apoptosis.
In recent years, PI3K signaling has moved to the forefront as
a central pathway affecting peripheral B cell maturation. Class
IA PI3K molecules are composed of regulatory (p85a, p55a,
p50a, and p85b) and catalytic (p110a, p110b, and p110d)
subunits and phosphorylate PI(4,5)P2 to generate the potent
yet transient secondary messenger PI(3,4,5)P3. Gene-targeting
studies show similar defects in follicular, B-1, and marginal
zone B cell subsets in Pik3cd/ and Pik3r1/ (encoding
p110d and p85a subunits, respectively) animals, indicating that
the p85a-p110d heterodimer is the most crucial form in B cells
(Fruman and Bismuth, 2009). Recruitment of PI3K to the BCRImmunity 31, 749–760, November 20, 2009 ª2009 Elsevier Inc. 749
Immunity
PI(3,4,5)P3 and B Cell Tolerancecomplex requires adaptor proteins bearing YXXM motifs that,
upon tyrosine phosphorylation, can bind the SH2 domain of
p85. Although cytosolic proteins such as the BCAP adaptors
may participate, the transmembrane adaptor CD19 appears to
be most crucial in recruiting PI3K (Aiba et al., 2007). In addition
to serving as the signal-transducing component of the C3d-
binding complement receptor CD21 (Rickert, 2005), CD19 inter-
acts via noncovalent interactions with components of the BCR
complex and thus is rapidly phosphorylated upon BCR cross-
linking (Carter et al., 1997). Accordingly, B cell defects observed
in CD19-deficient mice are similar in scope to that observed in
Pik3r1/ and Pik3cd/ mice (Fruman and Bismuth, 2009).
PI3K activity is directly antagonized by the D3 inositol phos-
phatase and tumor suppressor PTEN that, although subject to
regulation, is generally highly active and present at the plasma
membrane in both resting and activated cells (Tamguney and
Stokoe, 2007). Mice lacking PTEN in B cells possess enlarged
marginal zone and B-1 cell compartments and present a
‘‘hyper-IgM’’ phenotype because of enhanced plasma cell differ-
entiation and repressed class switch recombination (Anzelon
et al., 2003; Omori et al., 2006; Suzuki et al., 2003). Conversely,
most defects in peripheral B cell differentiation in mice lacking
the PI3K adaptor CD19 are reverted by the dual loss of PTEN
(Anzelon et al., 2003). Thus, the magnitude and duration of
PI(3,4,5)P3-dependent signaling is tightly regulated to govern B
cell growth, survival, and differentiation.
We sought to determine whether the PI3K pathway modifies
tolerogenic signaling in B cells. Using the hen egg lysozyme
(HEL) neo-self antigen mouse model, we found that PI(3,4,5)P3
was poorly generated in anergic B cells, resulting in reduced
Akt activation. This deficit is due at least in part to impaired tyro-
sine phosphorylation of CD19 and elevated expression of PTEN.
Importantly, PI(3,4,5)P3 repression directly contributes to tolero-
genic signaling, given that deletion of Pten results in failed B cell
anergy and enhanced responsiveness to BCR signaling in newly
formed B cells. These findings document the importance of the
PI3K pathway in B cell tolerance, which may interface with other
BCR-independent signaling pathways to govern the tolerogenic
state.
RESULTS
Reduced PI(3,4,5)P3 Induction in Anergic B Cells
Anergic B cells exhibit reduced activation of some BCR signaling
pathways. We hypothesized that the restriction of PI(3,4,5)P3
generation may also be a key component of the anergic state.
To investigate this possibility, we obtained naive splenic B cells
from MD4 transgenic mice that expressed an HEL-specific BCR
and compared themwith anergic B cells obtained fromMD4ML5
mice, which express the MD4 Ig transgene, as well as the ML5
transgene that encodes soluble HEL. Splenocytes from each
group were stimulated with anti-IgM F(ab’)2, fixed, and permea-
bilized and PI(3,4,5)P3 amounts were assessed in B cells (B220
+)
by intracellular staining with PI(3,4,5)P3-specific antibodies.
Upon stimulation, the amount of PI(3,4,5)P3 increased in MD4
B cells, but not in MD4ML5 B cells (Figure 1A). The scarcity of
PI(3,4,5)P3 would prevent the PH domain-dependent docking
and activation of Akt and other PH domain-bearing effectors.
To determine whether this is the case in MD4ML5 cells, we750 Immunity 31, 749–760, November 20, 2009 ª2009 Elsevier Incstimulated MD4 and MD4ML5 B cells and assessed Akt phos-
phorylation (S473) by immunoblotting. Akt phosphorylation
was induced in MD4 but not in MD4ML5 B cells upon stimulation
with anti-IgM F(ab’)2 (Figure 1B, upper panels). Consistent with
previous findings (Healy et al., 1997), Erk activation was basally
elevated in MD4ML5 B cells and induced in both MD4 and
MD4ML5 B cells (Figure 1B, upper panels). Because surface
IgM is selectively downmodulated in MD4ML5 B cells, stimula-
tions were also performedwith HEL antigen or anti-Igk to engage
both IgM and IgD receptors. Measurements of Ca2+ flux or Akt
(S473) phosphorylation was measured and found to be consis-
tent with the anti-IgM F(ab’)2 data (Figure S1 available online).
It is possible that dampened PI(3,4,5)P3 signaling in splenic
MD4ML5 B cells reflects the absence of marginal zone (MZ) B
cells, which appear to be hyper-responsive to BCR signaling
and are absent in MD4ML5 but present in MD4 mice (Mason
et al., 1992; Oliver et al., 1997). Accordingly, we found reduced
BCR-induced Akt activation in MD4 splenic B cells depleted of
MZ B cells (Figure S2). However, Akt activation was impaired
in MD4ML5 B cells relative to the follicular B cells from MD4
mice (Figure S2). Altogether, these findings indicate that PI3K
activity is inhibited and/or inositol phosphatase activity is
enhanced in anergic B cells.
CD19 Function in B Cell Anergy
Because the phosphorylation of CD19 upon BCR stimulation
leads to the recruitment and activation of PI3K, we assessed
whether signaling through CD19 was intact in anergic B cells.
MD4 and MD4ML5 B cells were stimulated with anti-IgM
F(ab’)2, and cell lysates were immunoblotted with antisera
specific for one of the phosphorylated tyrosine residues (Y513)
required for p85 binding to CD19. CD19 phosphorylation was
induced in MD4 B cells, but not in MD4ML5 B cells (Figure 1B,
lower panels). Surface expression of CD19 was unaltered in
MD4ML5 cells (data not shown). This result suggests that in
anergic B cells, Src kinase activity or functional association of
CD19 with the BCR complex may be impaired.
To determinewhether impaired CD19 signaling was a cause or
a consequence of anergy, we crossed MD4 and MD4ML5 mice
onto the Cd19/ background. It has been reported that CD19
promotes positive selection of newly formed Ig-positive B cells
(Buhl et al., 2000; Diamant et al., 2005); however, the role of
CD19 modulation of BCR signaling in mediating negative selec-
tion has not been addressed. Consistent with previous findings
(Buhl et al., 2000; Diamant et al., 2005), the loss of CD19 in
MD4 B cells resulted in a modest reduction in peripheral B cell
numbers (Figure 1C). Assessment of HEL-specific antibody re-
vealed that tolerance mechanisms to prevent autoantibody
production were intact in the absence of CD19 (Figure 1D).
Both MD4ML5 and MD4ML5 Cd19/ B cells selectively down-
regulated IgM (Figure 1E) and were short-lived, resulting in an
equally reduced splenic B cell compartment relative to their naive
counterparts (Figure 1C). Thus, altered BCR signaling thresholds
in the absence of CD19 do not affect anergy induction.
PTEN Function in B Cell Anergy
PI(3,4,5)P3 is rapidly hydrolyzed to PI(4,5)P2 by the lipid phos-
phatase PTEN, which we hypothesize is another means bywhich
PI(3,4,5)P3 availability is regulated in autoreactive B cells..
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Figure 1. PI3kinase Signaling and CD19 Activation Are Inhibited in Anergic B Cells
(A) Splenic cells from MD4 (left panel) and MD4ML5 (right panel) mice were stimulated with anti-IgM F(ab’)2 (blue) or left unstimulated (red) for 5 min. Cells were
fixed, permeabilized, stained with antibodies against B220 and PI(3,4,5)P3, and analyzed by flow cytometry.
(B) As shown in the upper panel, purifiedMD4 andMD4ML5 B cells were stimulated with anti-IgM F(ab’)2 for the indicated times. Cell lysates were immunoblotted
with anti-phosphorylated Akt (S473), anti-phosphorylated Erk, and anti-actin. As shown in the lower panels, purified MD4 and MD4ML5 B cells were stimulated
with anti-IgM F(ab’)2 for the indicated times. Cell lysates were immunoblotted with anti-phosphorylated CD19 (Y513) and anti-CD19.
(C) Splenic B cells of MD4-Cd19+/+, MD4ML5-Cd19+/+, MD4-Cd19/, and MD4ML5-Cd19/ mice were enumerated.
(D) HEL-specific IgM titers from MD4-Cd19+/+, MD4ML5-Cd19+/+, MD4-Cd19/, and MD4ML5-Cd19/ mice were determined by ELISA.
(E) IgM and IgD profiles of B cells from MD4-Cd19+/+, MD4ML5-Cd19+/+, MD4-Cd19/, and MD4ML5-Cd19/ mice were determined by flow cytometry.To assess PTEN protein expression in naive and anergic B cells,
we prepared whole-cell lysates from MD4 and MD4ML5 B cells
and immunoblotted them for PTEN expression. Interestingly,
PTEN protein expression was found to be higher in MD4ML5 B
cells compared to MD4 B cells (Figure 2A). Flow cytometric anal-
ysis revealed similar amounts of PTEN in the MZ and follicular B
cell compartments of MD4 mice (data not shown). Given that
modest changes in PTEN expression can have striking effects
on cellular responses, these results suggest that PTEN may be
required to suppress signaling via the PI3K pathway in autoreac-
tive B cells.
Because PI(3,4,5)P3 induction is reduced in anergic B cells, we
postulated that inactivation of PTEN in maturing B cells would
result in elevated PI(3,4,5)P3 and the unabated activation of
downstream effector molecules would cause a break in B cell
tolerance. To test this hypothesis, we crossed MD4 mice and
MD4ML5 mice with Ptenflox/flox-Cd19-Cre mice to inactivate
Pten specifically in B cells and to allow for the analysis of B
cell anergy induction and maintenance. The MD4, MD4ML5,
MD4-Ptenflox/flox, and MD4ML5-Ptenflox/flox animals used were
all heterozygous for Cd19 and express Cre recombinase. BCR-
induced PI(3,4,5)P3 generation was measured in splenic cells
obtained from MD4-Ptenflox/flox and MD4ML5-Ptenflox/flox mice.
Splenic cells were stimulated with anti-IgM F(ab’)2, intracellularly
stained with anti-PI(3,4,5)P3, and analyzed by flow cytometry
(Figure 2B). In contrast to the inhibition of PI(3,4,5)P3 induction
seen in MD4ML5 B cells (Figure 1A), MD4ML5-Ptenflox/floxB cellsshowed an increase in PI(3,4,5)P3 upon stimulation (Figure 2B).
Downstream signaling was assessed by measuring Ca2+ flux in
MD4, MD4ML5, MD4-Ptenflox/flox, and MD4ML5-Ptenflox/flox B
cells stimulated with anti-IgM F(ab’)2 or HEL antigen. As ex-
pected, MD4 B cells mobilized Ca2+ efficiently when stimulated
with either anti-IgM F(ab’)2 or HEL, whereas MD4ML5 B cells
did not (Figure 2C, left panels). In contrast, MD4-Ptenflox/flox
and MD4ML5-Ptenflox/flox B cells were both able to mobilize
Ca2+ (Figure 2C, right panels), indicating the continued ability
to induce productive BCR signaling. To further confirm the resto-
ration of BCR signaling in MD4ML5-Ptenflox/flox B cells, we
prepared lysates from anti-IgM- or anti-Igk stimulated-
MD4ML5 and MD4ML5-Ptenflox/flox B cells and immunoblotted
them for activated Akt (Figure 2D and Figure S3). Whereas Akt
was not activated in MD4ML5 B cells, MD4ML5-Ptenflox/flox B
cells efficiently activated Akt (Figure 2D and Figure S3). Erk
was basally phosphorylated in MD4ML5 but not MD4ML5-
Ptenflox/flox B cells, although it was inducible in both B cell types
(Figure 2D, lower panels). These results suggest that the loss of
Pten prevents B cells from acquiring a biochemical profile
consistent with the anergic state.
The hallmarks of B cell anergy include the selective downregu-
lation of surface IgM, as well as limited cell lifespan and prolifer-
ation and an inability to become immunoglobulin-secreting cells.
Therefore, we sought to determine whether the observed
recovery of productive BCR signaling by autoreactive PTEN-
deficient B cells translated into increased B cell numbers in theImmunity 31, 749–760, November 20, 2009 ª2009 Elsevier Inc. 751
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Figure 2. PTEN Protein Expression Is Increased in Anergic B Cells and PI3 Kinase Signaling Is Recovered in PTEN-Deficient B Cells
(A) Purified B cells from MD4 and MD4ML5 mice were lysed and immunoblotted with anti-PTEN or anti-actin.
(B) Splenic cells from MD4- Ptenflox/flox and MD4ML5-Ptenflox/flox mice were stimulated with anti-IgM F(ab’)2 (blue) or left unstimulated (red) for 5 min. Cells were
fixed, permeabilized, stained with antibodies against B220 and PI(3,4,5)P3, and analyzed by flow cytometry.
(C) Purified splenic B cells from MD4, MD4ML5, MD4-Ptenflox/flox, and MD4ML5-Ptenflox/flox mice were stimulated with 10 mg/ml HEL (upper panels) or 10 mg/ml
anti-IgM F(ab’)2 (lower panels), and Ca
2+ flux was measured by Fluo-4(530 nm)/Fura Red(685 nm) emission ratiometry. MD4 and MD4-Ptenflox/flox cells are
depicted in red, whereas MD4ML5 and MD4ML5-Ptenflox/flox cells are depicted in blue.
(D) Purified MD4, MD4ML5, MD4-Ptenflox/flox, and MD4ML5-Ptenflox/flox splenic B cells were stimulated with anti-IgM F(ab’)2 for the indicated times, and cell
lysates were immunoblotted with antibodies against phosphorylated Akt (S473), total Akt, phosphorylated Erk, and total Erk.periphery and increased titers of serum autoantibody. Although
MD4ML5 mice had low splenic and lymph node B cell numbers
compared to their naive counterparts, the B cell compartment in
MD4ML5-Ptenflox/flox mice was comparable to their naive coun-
terparts (Figure 3A and Figure S4). Interestingly, the MZ B cell
compartment is restored in MD4ML5-Ptenflox/flox mice, but is
not expanded to the extent observed in MD4-Ptenflox/flox mice
(Figure S5). The ability of B cells to secrete immunoglobulin
was assessed by measuring HEL-specific serum IgM titers by
ELISA. We found that whereas MD4 mice had substantially
higher serum IgM titers than MD4ML5 mice, MD4-Ptenflox/flox
mice and MD4ML5-Ptenflox/flox mice both maintained high titers
of serum IgM (Figure 3B). Furthermore, whereasMD4ML5B cells
dramatically downregulated surface IgM,MD4ML5-Ptenflox/floxB
cells did so to a lesser extent (Figure 3C). These results demon-
strate that the loss of PTEN leads to failed anergy and the
production of abundant autoantibody.
Effects of PTEN Loss on Self-Antigen Availability
and Receptor Occupancy
Secretion of autoantibody or the expression of autoreactive B
cell receptors can effectively sequester self-antigen and impact752 Immunity 31, 749–760, November 20, 2009 ª2009 Elsevier Inc.B cell tolerance, given that continued B cell receptor occupancy
is necessary for themaintenance of tolerance (Gauld et al., 2005;
Goodnow et al., 1989). Receptor occupancy, as defined by the
amount of HEL bound to the surface of B cells, was measured
in MD4, MD4ML5, and MD4ML5-Ptenflox/flox B cells by flow cy-
tometry with a polyclonal HEL antibody. We found that freshly
isolated MD4ML5-Ptenflox/flox B cells had 10-fold lower bound
HEL than MD4ML5 B cells (Figure 4A). This finding suggests that
receptor occupancy in vivo is reduced on autoreactive Pten-
deficient B cells, which may contribute to the inability to maintain
tolerance. Low receptor occupancy resulting in the increased
presence of autoreactive B cells may be more prominent in adult
mice as serum IgM titers accumulate and deplete available HEL.
To address this possibility, we quantified receptor occupancy in
adult (>8 weeks old) and young (3 weeks old) mice by incubating
splenic B cells with excess exogenous HEL to fully occupy
surface receptors. The amount of surface HEL on these cells
was compared to the amount of surface HEL on cells treated
with PBS alone; hence, the degree of receptor occupancy was
determined as the ratio of the mean fluorescence intensities
(MFI) of the PBS- and HEL-treated samples. In adult MD4ML5
mice, the amount of surface HEL on PBS-treated B cells was
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Figure 3. MD4ML5 PTEN-Deficient Mice Do Not Display an Anergic Phenotype
(A) Splenic B cells from MD4, MD4ML5, MD4-Ptenflox/flox, and MD4ML5-Ptenflox/flox mice were enumerated.
(B) HEL-specific serum IgM titers from MD4, MD4ML5, MD4-Ptenflox/flox, and MD4ML5-Ptenflox/flox mice were determined by ELISA.
(C) IgM and IgD profiles of B cells from MD4, MD4ML5, MD4-Ptenflox/flox, and MD4ML5-Ptenflox/flox mice were determined by flow cytometry.50% that of HEL-treated B cells (Figure 4B), which has been
previously reported as sufficient MD4 receptor occupancy by
endogenous antigen to induce and maintain tolerance (Good-
now et al., 1989). Consistent with the hypothesized sequestra-
tion of HEL by secreted or membrane-bound IgM in adult
MD4ML5-Ptenflox/flox mice, only 10% of MD4 receptors were
occupied by endogenous HEL (Figure 4B). Interestingly, in young
mice, receptor occupancy on both MD4ML5 and MD4ML5-
Ptenflox/flox B cells was approximately equivalent (60%)
(Figure 4B), suggesting a cumulative effect of self-antigen
sequestration in MD4ML5-Ptenflox/flox mice.
To qualitatively assess HEL antigen expression in MD4ML5-
Ptenflox/flox mice, we introduced CFSE-labeled MD4 B cells into
MD4ML5 and MD4ML5-Ptenflox/flox mice by tail-vein injection
and measured the downregulation of surface IgM upon acute
in vivo antigen encounter. We found that donor MD4 B cells
downregulated surface IgM strongly when exposed for 24 hr to
the adult MD4ML5 environment, suggesting a productive
encounter with HEL antigen (Figure 4C). In contrast, when donor
MD4 B cells were exposed to the adult MD4ML5-Ptenflox/flox
environment, surface IgM expression was downregulated to a
lesser extent (Figure 4C). In both cases, the downregulation of
surface IgM was antigen dependent because donor MD4 B cells
transferred into non-HEL-expressing MD4 and MD4-Ptenflox/flox
environments maintained similarly high basal expression of
surface IgM (Figure 4C). Thus, less HEL is available in adult
MD4ML5-Ptenflox/flox animals for inducing and sustaining anergy.
As previously reported (Schmidt and Cyster, 1999), acute
encounter with HEL leads to the elimination of antigen-specific
MD4 B cells in vivo. MD4, MD4-Ptenflox/flox, and MD4ML5-
Ptenflox/flox mice were administered exogenous HEL or PBS,
and splenocytes were harvested 48 hr later for assessment of
splenic B cell numbers, surface IgM downregulation, and upre-
gulation of CD86. The introduction of exogenous HEL induced
a measurable decrease in surface IgM in all groups, whereas
CD86 was only upregulated on MD4-Ptenflox/flox B cells (data
not shown). Importantly, MD4-Ptenflox/flox and MD4ML5-
Ptenflox/flox B cells expanded or persisted in the presence of
additional HEL, respectively (Figure 4D), whereas MD4 B cells
were eliminated. These findings indicate that increasing the
concentration of free self-antigen confers an anergic phenotype
on MD4ML5-Ptenflox/flox B cells, but they remain long-lived.The frequency of autoreactive B cells in normal mice is rela-
tively low, and the abundance of anti-HEL B cells in the
MD4ML5 system affects the concentration of available HEL
self-antigen. Therefore, bone marrow chimeras were generated
for assessing whether the ability of PTEN-deficient, self-reactive
B cells to escape the induction of anergy was independent of
their frequency within the B cell repertoire. Lethally irradiated
ML5 mice were reconstituted with a donor population of
lineage-depleted hematopoietic stems cells composed of a
20:80 mixture of either nonTg:MD4 or nonTg:MD4-Ptenflox/flox
cells. After 12 weeks of reconstitution, we found that despite
similar seeding frequencies, MD4-Ptenflox/flox B cells survived
and produced abundant autoantibody, whereas MD4 B cells
were present at a lower frequency and produced little autoanti-
body (Figure 5), consistent with previous findings (Cyster et al.,
1994). These results confirm that PTEN deficiency in self-
reactive B cells impairs the induction or maintenance of the
anergic state.
Immature PTEN-Deficient B Cells Are Less Sensitive
to Tolerogenic Signals
Negative selection takes place at the immature B cell stage
during which engagement of the B cell receptor with self-antigen
leads to B cell anergy or death. One of the cellular strategies
to induce anergy is through intrinsic negative regulation of
key signaling components. To determine the contribution of
PI(3,4,5)P3 signaling to negative selection of newly formed B
cells expressing a normal diverse repertoire of B cell receptors,
we measured the activation and proliferation in response to
BCR engagement of cultured immature B cells from nontrans-
genic wild-type and Ptenflox/flox mice. Bone marrow from non-
transgenic wild-type and Ptenflox/flox mice were harvested and
cultured with IL-7 over a 6 day period for promoting the selective
expansion of pre-B cells. Cells were then labeled with CFSE and
either returned to IL-7 or removed from IL-7 so that they could
transition to immature IgM-expressing B cells. In the latter
culture, B cells were treated with anti-IgM F(ab’)2 fragments
(1 or 10 mg/ml) to engage the BCR on newly formed IgM-positive
cells. B cells (B220+) were enumerated and examined for an acti-
vated profile (CD86+, increased forward scatter) as well as prolif-
erative capacity (CFSE partitioning) over a 3 day period. CD86
staining showed a 7-fold enhancement in the frequency ofImmunity 31, 749–760, November 20, 2009 ª2009 Elsevier Inc. 753
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Figure 4. MD4ML5 PTEN-Deficient B Cells Exhibit Low Receptor Occupancy
(A) Surface HEL staining of MD4 (green), MD4ML5 (blue), and MD4ML5-Ptenflox/flox (red) B cells was determined by flow cytometry.
(B) MD4, MD4ML5, and MD4ML5-Ptenflox/flox splenic cells from adult mice (>8 weeks old; upper panels) and young mice (3 weeks old; lower panels) were incu-
bated in 20 mg/ml HEL (blue) or PBS (red). Surface HEL was detected with polyclonal antibody against HEL and measured by flow cytometry. As shown in the bar
graph (bottom), percent receptor occupancy was determined from the ratio of HEL staining intensity of PBS-incubated cells to HEL-incubated cells. The asterisk
indicates a p value of < 0.05.
(C) MD4 B cells were CFSE-labeled and equal cell numbers were transferred into MD4ML5 (blue), MD4ML5-Ptenflox/flox (red), MD4-Ptenflox/flox (dotted), and MD4
(black) recipient mice by tail-vein injection. After 24 hr, recipient splenic cells were harvested and stained with anti-B220 and anti-IgM. CFSE+ donor B cells were
gated, and surface IgM was analyzed by flow cytometry.
(D) MD4, MD4-Ptenflox/flox, andMD4ML5-Ptenflox/floxmice were injected with HEL (blue) with three mice per group or PBS (red) with onemouse per group. Splenic
cells were isolated at 48 hr postinjection, enumerated, and examined for expression of B220 by flow cytometry. Histograms represent B220-positive cells.activated immature Ptenflox/flox B cells relative to immature wild-
type B cells (Figure 6A). Gating on activated B cells revealed that
immature Ptenflox/floxB cells proliferated to amuch greater extent
than immature wild-type B cells (Figure 6B). These findings
suggest that sustained PI(3,4,5)P3 signaling converts what is
normally a tolerogenic response into a mitogenic response
during B cell development.
Neonatal B cells exhibit phenotypic and functional character-
istics similar to that of immature B cells of adult bone marrow. To754 Immunity 31, 749–760, November 20, 2009 ª2009 Elsevier Inc.assess the effects of PI(3,4,5)P3 signaling on tolerance induction
during this developmental stage, we analyzed 5-day-old
neonatal littermates consisting of nontransgenic wild-type and
nontransgenic Ptenflox/flox mice. Interestingly, neonatal spleens
were not markedly enlarged in Ptenflox/flox mice as we typically
see in adult Ptenflox/flox mice (Anzelon et al., 2003). Moreover,
surface IgM and IgD profiles of wild-type and Ptenflox/flox B cells
from neonatal spleens revealed similarly high frequencies of
IgM+IgD B cells compared to adult B cells, which are largely
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Figure 5. MD4ML5 PTEN-Deficient B Cells Evade Anergy in Mixed Bone Marrow Chimeras
(A) Reconstitution with mixed bone marrow HSCs consisting of Non-Tg wild-type (20%) plus either MD4 (80%, left panel) or MD4-Ptenflox/flox (80%, right panel)
in ML5 recipients (n = 3 for each group). The frequencies of HEL-specific B cells were determined after 12 weeks of reconstitution.
(B) Sera from bone marrow chimeric recipient animals were analyzed for HEL-specific IgM by ELISA. Absorbances are depicted in the bar graph. Each bar
represents the average of three chimeric mice.IgM+IgD+ (Figure 6C, left panels). Using established protocols
(Chang et al., 1991; Yellen et al., 1991), we harvested and
cultured B cells from neonatal and adult wild-type and Ptenflox/
flox mice in media containing IL-4 alone, IL-4 plus LPS, or IL-4
plus anti-IgM F(ab’)2. Proliferation was assessed by
3H-thymi-
dine incorporation (Figure 6C, right panel). Wild-type neonatal
B cells proliferated modestly in response to LPS, but no prolifer-
ation was observed in response to anti-IgM F(ab’)2, confirming
that BCR stimulation is inhibitory in wild-type neonatal B cells
(Figure 6C). In contrast, neonatal Ptenflox/flox B cells proliferated
strongly in response to both LPS and anti-IgM F(ab’)2 (Figure 6C).
These findings corroborate the results of the bone marrow
culture system (Figures 6A and 6B) and demonstrate that sus-
tained PI(3,4,5)P3 signaling leads to activation and proliferation
rather than inhibition and anergy in immature B cells upon BCR
engagement.
DISCUSSION
Despite the striking differences in responsiveness to antigen by
immature and mature B cells, the underlying biochemical bases
for these distinct responses are unclear. Because PI3K signaling
is central to cellular growth control, proliferation, and survival,
the current work focused on the role of the PI3K pathway in
the induction and maintenance of B cell anergy. In mature B
cells, BCR engagement leads to the rapid generation of
PI(3,4,5)P3 as a consequence of PI3K (p85 and p110) recruitment
to CD19 and membrane-proximal adaptor proteins. In anergic B
cells, we found that PI(3,4,5)P3 production was substantially
reduced. Consistent with this observation, CD19 was expressed
to a normal degree, but was not efficiently phosphorylated on the
tyrosine residues that mediate PI3K recruitment. This defect may
be a consequence of impaired tyrosine kinase activity, as has
been noted in anergic B cells (Cooke et al., 1994). Alternatively,
CD19 may be physically uncoupled from the BCR complex
upon chronic engagement of the BCR; such a mechanism has
been described for the redistribution of the Ig-a-Ig-b heterodimer
(Vilen et al., 1999), and recent data indicate that CD19 function is
crucial in the formation of and signaling by antigen-bound BCR
microclusters (Depoil et al., 2008). Interestingly, overexpressionof human CD19 has been shown to cause a break in tolerance
(Inaoki et al., 1997), probably resulting from a preferential asso-
ciation of human CD19 with the BCR (given that it interacts
inefficiently with murine CD21 [Hasegawa et al., 2001]). Coen-
gagement of the BCR and CD21-CD19 Complement Receptor
2 complex by C3d-bearing self-antigens can also overcome
peripheral tolerance (Del Nagro et al., 2005; Lyubchenko et al.,
2007), suggesting that forced recruitment of CD19 into the
BCR complex overcomes receptor desensitization to augment
PI3K activation.
Given these findings, it is perhaps not surprising that anergy
was not affected by the loss of CD19. By contrast, the loss of
CD19 appears to impair positive selection of newly formed B
cells in both immunoglobulin transgenic aswell as nontransgenic
Cd19/ mice (Buhl et al., 2000; Diamant et al., 2005). We have
confirmed that this is the case for the HEL system as Cd19/
MD4 mice have reduced peripheral B cells relative to wild-type
MD4 counterparts (Figure 1C). These findings suggest that
BCR-associated CD19 is critical for the propagation of weak
signals during positive selection, but is dispensable for negative
selection mediated by strong signals (such as binding of HEL by
the MD4 receptor). Consistent with this view are our previous
findings of reduced survival of follicular CD19-deficient B cells
responding to submitogenic ‘‘tonic’’ signaling but intact
antigen-driven responses to potent multivalent antigens (Otero
et al., 2003; Rickert et al., 1995).
In addition to impaired CD19 signaling, we found elevated
expression of PTEN in anergic B cells. Whereas loss of PTEN
expression is oncogenic in most cells, increased PTEN expres-
sion or stability can further suppress growth factor receptor
signaling (Tamguney and Stokoe, 2007). Given that PTEN loss
leads to failed anergy, we conclude that reduced PI(3,4,5)P3 is
not only a novel hallmark of anergic B cells but is also a prerequi-
site for anergy induction and maintenance. Relatedly, PI3K has
also been recently shown to negatively regulate receptor editing
by modulating RAG expression (Verkoczy et al., 2007).
PI(3,4,5)P3 is transiently induced upon cell activation and triggers
multiple downstream pathways via the recruitment of pivotal
PH domain-containing proteins. In addition to the BCR, signaling
via costimulatory receptors and accessory molecules is alsoImmunity 31, 749–760, November 20, 2009 ª2009 Elsevier Inc. 755
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(A) Nontransgenic wild-type and PTEN-deficient bone marrow B cells were purified, and cells were cultured in rIL-7 for 6 days. Cells were labeled with CFSE
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PI(3,4,5)P3 and B Cell Toleranceaugmented in the absence of PTEN (Anzelon et al., 2003; Suzuki
et al., 2003). Of particular interest is threshold-based signaling
via the BAFF-R, which utilizes the PI3K pathway and regulates
the fate of anergic B cells in concert with the BCR (Lesley
et al., 2004; Patke et al., 2006; Thien et al., 2004). Normal hypo-
responsive PI3K signaling downstream of the BCR and BAFF-R
in self-reactive B cells undergoing anergy could be overcome by
a loss of PTEN, resulting in a breach in tolerance. This hypothesis
predicts that haplo-insufficient or B cell-specific PTEN-deficient
animals would be prone to autoantibody production and autoim-
mune disease. Indeed, although autoantibody production has
been noted in Pten mutant mice (Di Cristofano et al., 1999;
Suzuki et al., 2003), we postulate that autoantibody-associated
disease is generally not observed because elevated PI3K
signaling negatively regulates class switch recombination and,
hence, the production of pathogenic IgG (Dengler et al., 2008;
Omori et al., 2006).
The strength of signaling via the BCR is the key determinant of
B cell fate after self-antigen encounter. Weak signals induced by
low-affinity and/or -avidity interactions induce the anergic state,
which can lead to apoptosis in the short term, but this fate can be
averted upon removal of antigen, change in BCR specificity, or
provision of costimulatory signals (Cooke et al., 1994; Cornall
et al., 1998; Gauld et al., 2005; Halverson et al., 2004; Healy
andGoodnow, 1998; Phan et al., 2003). In immunoglobulin trans-
genic systems, the affinity of the BCR for self-antigen is fixed;
however, the strength of signal can be modulated by the relative
amount or nature of the self-antigen (soluble versus membrane
bound). Given that membrane or secreted anti-HEL immuno-
globulin can deplete self-antigen, under some circumstances
local HEL may become subthreshold, resulting in the accumula-
tion of HEL-specific B cells that are ‘‘indifferent’’ or ‘‘ignorant’’ of
self-antigen. Early studies using the soluble HEL system showed
that receptor occupancy of 50% was sufficient to induce and
maintain anergy (Goodnow et al., 1989). This threshold corre-
lates with the in vivo positioning of anergic B cells in the outer
PALS (Cook et al., 1997; Cyster et al., 1994; Fulcher et al.,
1996) and can be recapitulated with the transfer of naive imma-
ture or mature Ig transgenic B cells into HEL transgenic recipi-
ents (Fulcher et al., 1996). Our B cell transfer and HEL infusion
experiments indicate that PTEN-deficient B cells in adult animals
are exposed to lower amounts of HEL and thus are less likely to
adopt the phenotypic and functional characteristics of anergy.
Nonetheless, we also demonstrate using mixed bone marrow
chimeras that PTEN loss causes an intrinsic defect in B cell
signaling, resulting in impaired induction of maintenance of B
cell anergy. These findings are consistent with our studies of
nontransgenic PTEN-deficient immature B cells that were iso-
lated from adult bone marrow or neonatal or adolescent mice
and that were found to be responsive to BCR signaling, indi-
cating a primary defect in tolerogenic signaling in newly formed
B cells that lack PTEN. These findings establish PI(3,4,5)P3
metabolism as a focal point for inducing and maintaining the
tolerogenic state in B cells, setting the stage for future studies
exploring the role of particular PI(3,4,5)P3 effectors in this
context.
In summary (Figure S6), we propose that elevated and sus-
tained activation of the PI3K pathway in newly formed B cells
results in altered negative selection and the egress of autoreac-tive B cells into the periphery. Once in the periphery, these cells
also appear to be refractory to elimination by the continued pres-
ence of self-antigen. Interestingly, because elevated PI3K
signaling favors MZ B cell formation (Anzelon et al., 2003; Suzuki
et al., 2003), selection into this compartment may promote the
propagation and further differentiation of autoreactive B cells in
response to BAFF, TLR ligands, and T cell-derived factors, as
others have suggested (Enzler et al., 2006; Thien et al., 2004).
In addition to these intrinsic effects, the accumulation of autor-
eactive B cells and secreted autoantibody will gradually se-
quester HEL, leading to the release and maturation of additional
‘‘clonally ignorant’’ B cells as a secondary event. This effect is
dramatically revealed with the monoclonal HEL system given
that self-reactive B cells are present in great abundance (even
in a mixed bone marrow chimera) and express or secrete high-
affinity immunoglobulin. However, the chronicity of autoimmune
disease and long-lived nature of antigen-selected B cells
support the broad premise that self-antigen depletion by autoan-
tibody may perpetuate autoimmunity through the continued
release of self-reactive bone marrow B cells, some of which
may persist and differentiate into autoantibody-producing cells
in the periphery.
EXPERIMENTAL PROCEDURES
Mice
Mice expressing MD4 (HEL-Ig transgene) and ML5 (sHEL transgene) were
obtained from Jackson Laboratories (Goodnow et al., 1988). These mice
were bred so that double transgenic mice (MD4ML5) could be obtained.
Ptenflox/flox mice (Lesche et al., 2002) were crossed with CD19cre mice (in
which cre recombinase expression is driven by the CD19 promoter [Rickert
et al., 1997]) for Ptenflox/flox-Cd19-Cre mice generation. Single-transgenic
(MD4) and double-transgenic (MD4ML5) mice were subsequently bred with
Ptenflox/flox-Cd19-Cre mice for obtaining naive (MD4) and autoreactive
(MD4ML5) mice with a B cell-specific Pten deletion. All animals were main-
tained in an animal facility, and experimental procedures were approved
by the IACUC committee at The Burnham Institute for Medical Research
(La Jolla, CA).
Immunoblotting
Splenic B cells were purifiedwithMACS beads for negative selection of B cells,
in accordance with the manufacturer’s recommended procedure (Miltenyi
Biotech). One to ten million B cells were washed with PBS and stimulated
with 10 mg/mL goat anti-mouse IgM F(ab’)2 (Jackson ImmunoResearch
Laboratories) for the indicated times at 37C. Cell pellets were lysed on ice
for 30 min in either RIPA lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM
NaCl, 2 mM EDTA, 1% NP-40, and 0.1% SDS) or NP-40 lysis buffer (20 mM
Tris-HCl [pH 7.5], 1% NP-40, 10% glycerol, 10 mM NaCl, and 1 mM EDTA)
plus protease inhibitors (2 mg/ml leupeptin, 2 mM PMSF, 2 mg/ml aprotinin,
and 1 mM sodium orthovanadate). Lysates were electrophoresed with
4%–12% acrylamide SDS gels and blotted onto nitrocellulose paper. Anti-
bodies against CD19, phospho-CD19, Akt, phospho-Akt, Erk, phospho-Erk,
and actin were from Cell Signaling Technology. Proteins were revealed with
HRP-labeled anti-rabbit antibodies and developed with SuperSignal West
Pico Chemiluminescent Substrate (Thermo Scientific).
Flow Cytometry
Spleens were excised and red blood cells depleted from cell suspensions with
hypotonic ammonium chloride. One million splenic cells were resuspended in
FACS buffer (PBS, 1% FBS, and 0.01% sodium azide) and incubated with the
following conjugated antibodies: IgM-APC, IgD-PE, B220-APC-Cy7, and
CD11b-PE-Cy7 (BD Bioscience or eBioscience). Samples were washed
with FACS buffer and analyzed with a FACSCanto flow cytometer and FlowJo
software (Treestar). For PI(3,4,5)P3 staining, 5 3 10
6 splenic cells wereImmunity 31, 749–760, November 20, 2009 ª2009 Elsevier Inc. 757
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PI(3,4,5)P3 and B Cell Toleranceresuspended in 100–200 ml PBS, preincubated at 37C for 5 min, and stimu-
lated with anti-IgM F(ab’)2 at a final concentration of 10 mg/ml at 37
C for
5 min. Cells were fixed with 1.5% formaldehyde at RT for 10 min, washed
with cold PBS, and resuspended in 500 ml permeabilization buffer (PBS, 1%
BSA, and 0.2% saponin) on ice for 10 min. Cells were subsequently stained
with biotinylated anti- PI(3,4,5)P3 IgM antibody (Echelon Biosciences) or bioti-
nylated IgM isotype control (BD Biosciences PharMingen) in permeabilization
buffer on ice for 30 min. Cells were washed twice with permeabilization buffer,
resuspended in the same buffer containing strepavidin-FITC and B220-APC-
Cy7, and analyzed by flow cytometry. For receptor occupancy, cells were
incubated in 20 mg/ml hen egg lysozyme (Sigma) or PBS on ice for 1 hr. Cells
were blocked with anti-mouse CD16-CD32, stained with biotinylated anti-hen
egg lysozyme (Rockland), and subsequently stained with strepavidin-PE and
anti-B220-APC-Cy7. Mean fluorescence intensities of PBS-treated cells
were divided by the corresponding mean fluorescence intensities of HEL-
treated cells and multiplied by 100 so that the percentage of receptor occu-
pancy was obtained.
Serum ELISA
Serum samples were collected by retroorbital bleeding. Ninety-six-well high-
binding-capacity plates were coated with 10 mg/ml HEL or anti-mouse IgM
for 24 hr at 4C. Plates were blocked for 1–2 hr at RT with blocking buffer
(0.5% BSA in PBS). Serum samples were serially diluted in blocking buffer
and incubated in coated wells for 2 hr at RT. Plates were washed and incu-
bated with alkaline phosphatase-conjugated anti-mouse IgM or conjugated
anti-mouse kappa (Southern Biotech) for 1 hr at RT. Phosphatase substrate
(Sigma) was added to wells, and A405 was measured with a BioTek Elx808
colorimetric plate reader (BioTek Instruments).
Cell Transfer
Purified B cells were incubated at 13 107 cells/ml for 10 min at RT in PBS con-
taining 5 mM CFDA-SE (Invitrogen). FCS was added to a final concentration of
10%, and cells were incubated for 15 min at RT. Cells were washed twice with
PBS and were injected via tail vein into recipient mice. After 18–26 hr, mice
were sacrificed and splenic cells were stained with antibodies against B220
and IgM, and CFSE+ cells were gated and analyzed by flow cytometry.
HEL Injection
Animals were immunized via intraperitoneal (i.p.) injection with either 1mg HEL
in PBS; this was followed 24 hr later with a second 1 mg HEL injection or with
a single 5 mg injection. Control mice were injected with PBS alone. Forty-eight
hours after the initial injection, animals were sacrificed and spleen suspensions
were prepared. For flow cytometric analysis of cellular activation, nonspecific
binding was first blocked by preincubating cells with anti-mouse CD16-CD32
blocking antibodies (eBioscience). Cells were then stained with biotin-
conjugated anti-mouse CD86 and subsequently stained with strepavidin-
PerCP-Cy5.5 (eBioscience), IgM-APC, and B220-APC-AF750 (eBioscience).
Calcium Flux
Two million B cells were resuspended in 250 ml media (DMEM, 10 mMHEPES,
and 2.5% FBS). Four ml Fura Red, 2 ml Fluo-4, and 2 ml pluronic acid (Molecular
Probes) were added to 1 ml of media. An equal volume of dye mix was added
to each cell suspension. Cells were incubated for 45 min at 37C in the dark,
washed with media, and stained with B220-APC. Stained cells were read for
1 min for obtaining a baseline on the flow cytometer and then stimulated
with either 10 mg/ml anti-IgM F(ab’)2 or 10 mg/ml hen egg lysozyme. Calcium
flux was measured by Fluo-4 (530 nm)/Fura Red (685 nm) emission ratiometry
for 5 min.
3H-Thymidine Incorporation
Purified B cells were cultured at 1 to 2 3 106 cells/ml in round-bottom 96-well
plates in 100–200 ml/well of RPMI complete medium in the presence of IL-4
(5 ng/ml) plus LPS (20 mg/ml) Serotype 0111:B4 (Sigma) or anti-IgM F(ab’)2
(20 mg/ml). Cells were cultured for 48 hr after which 3H-thymidine was added
for the last 16 hr at 1 mCi per well. Cells were harvested with a FilterMate
Harvester (PerkinElmer), and the amount of incorporated 3H-thymidine was
measured with a MicroBeta Trilux scintillation counter (PerkinElmer).758 Immunity 31, 749–760, November 20, 2009 ª2009 Elsevier Inc.Bone Marrow Culture
Mixed femoral bone marrow cells were treated with hypotonic solution for red
blood cell depletion for 5min on ice. B cells were purifiedwith anti-B220MACS
beads and cultured at 2 3 106 cells/ml in 6-well plates in 15% fetal bovine
serum in OptiMEM media containing 10 ng/ml rIL-7, 10 ng/ml SCF, and
10 ng/ml Flt3-L. After 6 days, nonadherent cells were collected in fresh media,
labeled with CFSE, and recultured in media containing IL-7 alone, 10 mg/ml
anti-IgM F(ab’)2, or 1 mg/ml anti-IgM F(ab’)2 and incubated for 3 days. Cells
were harvested and stained with 7AAD and antibodies to CD86 and B220.
Statistical Method
Student’s t test was used for determining statistically significant differences
between samples.
SUPPLEMENTAL DATA
Supplemental Data include six figures and can be found with this article online
at http://www.cell.com/immunity/supplemental/S1074-7613(09)00453-1.
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